Sites of metastases before systemic treatment influence progression patterns and survival in stage IV melanoma patients

I A Vergara; Serigne Lo; Isabel Li; Jordan W. Conway; Alexander M. Menzies; Matteo S. Carlino; Richard A Scolyer; Georgina V. Long; Inês Pires da Silva

doi:10.1016/j.iotech.2025.101078

Related publications

Article2023

Abstract 6747: Sites of metastases prior to systemic treatment influence progression patterns and survival in stage IV melanoma patients

Ismael A. Vergara, Serigne Lo, Isabel Li, Alexander M. Menzies, Matteo S. Carlino, Richard A Scolyer, Georgina V. Long, Inês Pires da Silva

Article2020

Circulating Tumor DNA Predicts Outcome from First-, but not Second-line Treatment and Identifies Melanoma Patients Who May Benefit from Combination Immunotherapy

Gabriela Marsavela, Jenny Lee, Leslie Calapre, Stephen Q. Wong, Michelle R. Pereira, Ashleigh C. McEvoy, Anna Reid, Cleo Robinson, Lydia Warburton, Afaf Abed, Muhammad A. Khattak, Tarek Meniawy, Sarah‐Jane Dawson, Shahneen Sandhu, Matteo S. Carlino, Alexander M. Menzies, Richard A. Scolyer, Georgina V. Long, Benhur Amanuel, Michael Millward, Mel Ziman, Helen Rizos, Elin S. Gray

Article2021

Melanoma brain metastases that progress on BRAF-MEK inhibitors demonstrate resistance to ipilimumab-nivolumab that is associated with the Innate PD-1 Resistance Signature (IPRES)

Peter K. H. Lau, Breon Feran, Lorey Smith, Arian Lasocki, Ramyar Molania, Kortnye Smith, Alison M. Weppler, Christopher Angel, Damien Kee, Prachi Bhave, Belinda Lee, Richard J. Young, Amir Iravani, Hanxian Aw Yeang, Ismael A. Vergara, David L. Kok, Kate Drummond, Paul J. Neeson, Karen E. Sheppard, Anthony T. Papenfuss, Benjamin Solomon, Shahneen Sandhu,

Article2013

Effects of <scp>BRAF</scp> inhibitors on human melanoma tissue before treatment, early during treatment, and on progression

Georgina V. Long, James S. Wilmott, Lauren E. Haydu, Varsha Tembe, Raghwa Sharma, Helen Rizos, John F. Thompson, Julie R. Howle, Richard A Scolyer, Richard Kefford

Article2021

The role of local therapy in the treatment of solitary melanoma progression on immune checkpoint inhibition: A multicentre retrospective analysis

Judith M. Versluis, Anne M. Hendriks, Alison M. Weppler, Lauren Brown, Karlijn de Joode, Karijn P.M. Suijkerbuijk, Lisa Zimmer, Ellen Kapiteijn, Clara Allayous, Douglas B. Johnson, Adriana Hepner, Joanna Mangana, Prachi Bhave, Yanina Jansen, Claudia Trojaniello, Victoria Atkinson, Lucy Storey, Paul Lorigan, Paolo A. Ascierto, Bart Neyns, Andrew Haydon, Alexander M. Menzies, Georgina V. Long,